Overview

A Study of NT 201 Doses in the Treatment of Platysma Prominence

Status:
Not yet recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of NT 201 in adults with moderate to severe platysma prominence.
Phase:
Phase 2
Details
Lead Sponsor:
Merz Aesthetics GmbH
Treatments:
Botulinum Toxins, Type A
incobotulinumtoxinA